Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
3 hours ago
3 hours ago
Listen to key experts from a multidisciplinary team consider the strategies to avoid, mitigate, identify and effectively manage side effects associated with ADCs in patients with metastatic breast cancer.
The multidisciplinary team
- Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
- Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
- Clinical oncology pharmacy specialist: Dr Scott Edwards, Dr. H. Bliss Murphy Cancer Center, St. John’s, Newfoundland, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
3 hours ago
3 hours ago
Listen to key experts from a multidisciplinary team discuss effective strategies for communicating the potential side effects associated with ADC treatment to patients with metastatic breast cancer.
The multidisciplinary team
- Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
- Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
- Patient advocate: Mrs Lesley Turner, Independent Cancer Patients’ Voice, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
3 hours ago
3 hours ago
Listen to key experts from a multidisciplinary team review and discuss the safety profiles of current and emerging ADCs in patients with metastatic breast cancer.
The multidisciplinary team
- Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
- Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
13 hours ago
13 hours ago
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to retina specialist Prof. Peter Kaiser answer a series of questions on the current clinical landscape for neovascular age-related macular degeneration and diabetic macular oedema, share his perspective on how newly available treatments are influencing the existing standard of care and provide guidance on how new therapies can be effectively integrated into clinical practice.
The expert
- Prof. Peter Kaiser, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA
This touchPODCAST is for HCPs outside of the USA and UK only.
This activity is funded by an independent medical education grant from Bayer Consumer Care AG.
The activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchophthalmologyime.org/adopting-emerging-therapies-for-retinal-diseases
Tuesday Mar 18, 2025
Tuesday Mar 18, 2025
touchCONGRESS for touchCARDIO
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, German
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
Tuesday Mar 18, 2025
Tuesday Mar 18, 2025
touchCONGRESS for touchENDOCRINOLOGY
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
Tuesday Mar 18, 2025
Tuesday Mar 18, 2025
touchCONGRESS for touchNEUROLOGY
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
Tuesday Mar 18, 2025
Tuesday Mar 18, 2025
touchCONGRESS for touchRESPIRATORY
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
Thursday Mar 06, 2025
Thursday Mar 06, 2025
touchMDT for touchONCOLOGY
Listen to experts Dr Alicia Morgans, Dr Grace Cullen, and patient advocate, Mr Tony Collier, discuss the importance and practicalities of engaging patients in their care and hear insights from the perspective of a patient advocate in relation to the use of PARP inhibitors.
The multidisciplinary team and patient advocate:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
Patient Advocate – Mr Tony Collier
Tackle Prostate Cancer, London, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is supported by an independent medical education funding request from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/
Thursday Mar 06, 2025
Thursday Mar 06, 2025
touchMDT for touchONCOLOGY
Somatic and germline testing are key in managing metastatic castration-resistant prostate cancer (mCRPC). Listen as Prof. Albrecht Stenzinger shares his perspectives as a pathologist with Dr Alicia Morgan and Dr Grace Cullen.
The multidisciplinary team:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
Pathologist – Prof. Albrecht Stenzinger
University of Heidelberg, Heidelberg, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is supported by an independent medical education funding request from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/